Spine

K2M’s IPO could reap as much as $183M

K2M says its forthcoming initial public offering could garner as much as $183 million, if its underwriters exercise a 1.3 million-share over-allotment.

K2M's IPO could reap as much as $183M

K2M Group Holdings, the largest privately held spinal implant maker, said today that its forthcoming initial public offering could be worth up to $183 million.

K2M announced its plans for a U.S. IPO early this year, saying in March that the launch could be worth $100 million.

 

Read the rest at MassDevice

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close